Szela Mary T. - 29 Jan 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: CEO AND PRESIDENT, Director
Signature: /s/ Sean Murphy, Attorney-in-Fact
Issuer symbol: TLSI
Transactions as of: 29 Jan 2025
Net transactions value: +$51,754
Form type: 4
Filing time: 31 Jan 2025, 17:54:39 UTC
Previous filing: 29 Jan 2025
Next filing: 19 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TLSI	Common Stock	Purchase	$25,301	+5,030	+1.2%	$5.03	439,249	29 Jan 2025	Direct
transaction	TLSI	Common Stock	Purchase	$26,453	+5,010	+1.1%	$5.28	444,259	30 Jan 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.